Effects of synthetic form of tracheal antimicrobial peptide on respiratory pathogens

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 3, 1996, Pages 599-604

  Lawyer, Carl ^a   Pai, Sudha ^a   Watabe, Misako ^a   Bakir, Haithem ^a   Eagleton, Lanie ^a   Watabe, Kounosuke ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; PEPTIDE;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BACTERICIDAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYSTIC FIBROSIS; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; GROWTH INHIBITION; NONHUMAN; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ASPERGILLUS FUMIGATUS; CYSTIC FIBROSIS; ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDE FRAGMENTS; PEPTIDES; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTIONS;

EID: 0029983709     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.3.599     Document Type: Article

References (11)

1. Baley, J. E., Mayers, C., Kliegman, R. M., Jacobs, M. R. & Blamer, J. L. (1990). Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. Journal of Pediatrics 116, 791-7.
2. Borgia, P. T. & Dodge, C. L. (1992). Characterization of Aspergillus nidulans mutants deficient in cell wall chitin or glucan. Journal of Bacteriology 174, 377-82.
3. Diamond, G., Jones, D. E. & Bevins, C. (1993). Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene. Proceedings of the National Academy of Sciences of the United States of America 9, 4596-600.
4. Diamond, G., Zasloff, M., Eck, H., Brasseur, M., Maloy, W. L. & Bevins, C. L. (1991). Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of cDNA. Proceedings of the National Academy of Sciences of the United States of America 88, 3952-6.
5. Duclohier, H., Molle, G. & Spach, G. (1989). Antimicrobial peptide magainin I from Xenopus skin forms anion-permeable channels in planar lipid bilayers. Biophysical Journal 56, 1017-21.
6. Ganz, T., Selsted, M. E. & Lehrer, R. I. (1990). Defensins. European Journal of Haematology 44, 1-8.
7. Jacob, L. & Zasloff, M. (1994). Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Foundation Symposium 186, 197-223.
8. Knowles, M., Gilligan, P. & Boucher, R. (1995). Cystic Fibrosis. In Infectious Diseases (Mandell, G., Bennett, J. & Dolin, R., Eds), pp. 657-99. Churchill-Livingstone, Edinburgh.
9. Knutsen, A. & Slavin, R. G. (1992). Allergic bronchopulmonary mycosis complicating cystic fibrosis. Seminars in Respiratory Infections 7, 179-92.
10. Lehrer, R. I., Rosenman, M., Harwig, S. S., Jackson, R. & Eisenhauer, P. (1991). Ultrasensitive assays for endogenous antimicrobial polypeptides. Journal of Immunological Methods 137, 167-73.
11. Martin, D. W., Schurr, M. J., Mudd, M. H., Govan, J. R., Holloway, B. W. & Deretic, V. (1993). Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proceedings of the National Academy of Sciences of the United States of America 90, 8377-81.